Reactions Pharmacovigilance Service
Monitoring the safety of marketed medicines and taking action to increase benefit and reduce risk is becoming an increasingly important consideration in drug development and product management.
Driven and enforced by regulatory agencies such as the EMEA and FDA, marketing authorization holders are required to monitor the literature for adverse drug reactions (ADR) on a weekly basis. Streamline your compliance to these regulations with confidence using our Reactions Pharmacovigilance Service, designed to facilitate your ICSR monitoring obligations.
Have confidence that nothing is missed as a result of our extensive coverage and variety of sources
- All relevant international journals – approximately 8000 unique titles plus companion supplements
- Proceedings from approximately 100 major scientific meetings
- Newsletters from the national centres participating in the WHO International Drug Monitoring Programme
- Regulatory agency & pharmaceutical company websites
- Media releases
Easily integrate into your existing Pharmacovigilance process by customizing content, delivery, and timing to meet your needs:
- Monitor specific drugs or drug classes
- Delivery through an XML data feed or email alerts
- E2B compatible data feed has all relevant ICH E2B(M) fields populated, including the latest version of MedDRA coding
- Daily, weekly, or monthly alerts available
- ICSRs are processed on a daily basis
Additional services are also available to help you meet your safety reporting obligations
- Aggregate safety searches
- Local language journal monitoring